FOSAPREPITANT DIMEGLUMINE

N/A

Manufactured by Merck Sharp & Dohme LLC

48,249 FDA adverse event reports analyzed

Last updated: 2026-04-14

About FOSAPREPITANT DIMEGLUMINE

FOSAPREPITANT DIMEGLUMINE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Merck Sharp & Dohme LLC. The most commonly reported adverse reactions for FOSAPREPITANT DIMEGLUMINE include NAUSEA, DYSPNOEA, PYREXIA, DIARRHOEA, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FOSAPREPITANT DIMEGLUMINE.

Top Adverse Reactions

NAUSEA1,431 reports
DYSPNOEA1,197 reports
PYREXIA1,076 reports
DIARRHOEA1,067 reports
VOMITING1,038 reports
FATIGUE1,019 reports
OFF LABEL USE846 reports
ALOPECIA834 reports
RASH817 reports
FEBRILE NEUTROPENIA786 reports
HYPERSENSITIVITY779 reports
PRURITUS697 reports
INFUSION RELATED REACTION678 reports
STOMATITIS636 reports
PAIN610 reports
GENERAL PHYSICAL HEALTH DETERIORATION601 reports
DECREASED APPETITE594 reports
CONFUSIONAL STATE590 reports
INFECTION573 reports
ARTHRALGIA564 reports
ASTHENIA559 reports
HEPATIC ENZYME INCREASED558 reports
MALAISE546 reports
GASTROINTESTINAL DISORDER530 reports
INSOMNIA523 reports
ABDOMINAL DISCOMFORT522 reports
IMPAIRED HEALING515 reports
WEIGHT INCREASED514 reports
GLOSSODYNIA503 reports
FOLLICULITIS499 reports
DUODENAL ULCER PERFORATION498 reports
HAND DEFORMITY496 reports
SYSTEMIC LUPUS ERYTHEMATOSUS494 reports
DEATH482 reports
SWELLING479 reports
CONTUSION477 reports
HEADACHE477 reports
SINUSITIS477 reports
BLISTER476 reports
ILL DEFINED DISORDER476 reports
DISCOMFORT475 reports
HELICOBACTER INFECTION475 reports
NASOPHARYNGITIS474 reports
CONDITION AGGRAVATED471 reports
JOINT SWELLING459 reports
SYNOVITIS454 reports
LOWER RESPIRATORY TRACT INFECTION452 reports
ABDOMINAL PAIN450 reports
NEUTROPENIA450 reports
WOUND448 reports
PERIPHERAL SWELLING447 reports
RHEUMATOID ARTHRITIS446 reports
THROMBOCYTOPENIA445 reports
ARTHROPATHY442 reports
IRRITABLE BOWEL SYNDROME442 reports
ANTI CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE439 reports
ERYTHEMA438 reports
MUSCLE INJURY438 reports
DIZZINESS436 reports
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE434 reports
PERICARDITIS430 reports
PNEUMONIA430 reports
PEMPHIGUS415 reports
HYPERTENSION409 reports
INJURY393 reports
SLEEP DISORDER384 reports
CHEST PAIN380 reports
DRUG INEFFECTIVE373 reports
WEIGHT DECREASED369 reports
ANAEMIA365 reports
ABDOMINAL PAIN UPPER362 reports
BACK PAIN356 reports
URTICARIA355 reports
CONTRAINDICATED PRODUCT ADMINISTERED341 reports
OEDEMA PERIPHERAL327 reports
ANXIETY325 reports
PARAESTHESIA325 reports
DRUG HYPERSENSITIVITY321 reports
FLUSHING320 reports
HYPOTENSION312 reports
HYPOAESTHESIA306 reports
CONSTIPATION300 reports
WHEEZING297 reports
WHITE BLOOD CELL COUNT DECREASED287 reports
MATERNAL EXPOSURE DURING PREGNANCY285 reports
LIVER DISORDER282 reports
ACUTE KIDNEY INJURY278 reports
FEELING HOT270 reports
PAIN IN EXTREMITY270 reports
PLATELET COUNT DECREASED266 reports
RHEUMATOID FACTOR POSITIVE266 reports
DRY MOUTH264 reports
PRODUCT USE IN UNAPPROVED INDICATION262 reports
COUGH261 reports
DRUG INTOLERANCE256 reports
MOBILITY DECREASED255 reports
NEUTROPHIL COUNT DECREASED253 reports
C REACTIVE PROTEIN ABNORMAL252 reports
JOINT RANGE OF MOTION DECREASED250 reports
ROAD TRAFFIC ACCIDENT248 reports

Report Outcomes

Out of 13,275 classified reports for FOSAPREPITANT DIMEGLUMINE:

Serious 85.6%Non-Serious 14.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female7,589 (62.0%)
Male4,537 (37.1%)
Unknown111 (0.9%)

Reports by Age

Age 44602 reports
Age 65357 reports
Age 59333 reports
Age 66329 reports
Age 60323 reports
Age 62300 reports
Age 61297 reports
Age 63289 reports
Age 69285 reports
Age 68284 reports
Age 58270 reports
Age 70256 reports
Age 67254 reports
Age 64241 reports
Age 56233 reports
Age 57233 reports
Age 55220 reports
Age 71220 reports
Age 72209 reports
Age 48203 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with FOSAPREPITANT DIMEGLUMINE?

This profile reflects 48,249 FDA FAERS reports that mention FOSAPREPITANT DIMEGLUMINE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for FOSAPREPITANT DIMEGLUMINE?

Frequently reported terms in FAERS include NAUSEA, DYSPNOEA, PYREXIA, DIARRHOEA, VOMITING, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures FOSAPREPITANT DIMEGLUMINE?

Labeling and FAERS entries often list Merck Sharp & Dohme LLC in connection with FOSAPREPITANT DIMEGLUMINE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.